AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 24, 2026, 09:49Christopher Robinson: Does Aspirin Prophylaxis Prevent Preterm Preeclampsia?
-
Feb 24, 2026, 09:00Oral GnRH-Ant Elagolix to Patients With Surgically Diagnosed Endometriosis – RBMO
-
Feb 24, 2026, 06:35Adrian Hernandez Lopez on Comprehensive Pregnancy Care – AJOG MFM
-
Feb 24, 2026, 06:24Christopher Robinson: Postpartum Algorithm for Suspected Pulmonary Embolism
-
Feb 24, 2026, 04:48Beata Blazkova: Progress and Challenges of AI Adoption in Czech Healthcare
-
Feb 24, 2026, 04:23Christine McCullum-Gomez: Intergenerational Effects of Toxic Exposure on Health Uncovered
-
Feb 24, 2026, 01:21Barbara Lawrenz: IVF/ICSI Treatment May Not Only Be a Blessing but Also a Dilemma
-
Feb 24, 2026, 01:07Verena Ehrbar: ESHRE SIG Psychology Calls for Young Professionals
-
Feb 24, 2026, 00:57Beata Blazkova: Would You Treat a 0.03 Difference as Decisive in Embryo Selection?